Correlation Between Microsoft and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and BioNTech SE, you can compare the effects of market volatilities on Microsoft and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and BioNTech.

Diversification Opportunities for Microsoft and BioNTech

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Microsoft and BioNTech is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Microsoft i.e., Microsoft and BioNTech go up and down completely randomly.

Pair Corralation between Microsoft and BioNTech

Given the investment horizon of 90 days Microsoft is expected to generate 1.74 times less return on investment than BioNTech. But when comparing it to its historical volatility, Microsoft is 3.26 times less risky than BioNTech. It trades about 0.19 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  10,490  in BioNTech SE on September 1, 2024 and sell it today you would earn a total of  760.00  from holding BioNTech SE or generate 7.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy91.3%
ValuesDaily Returns

Microsoft  vs.  BioNTech SE

 Performance 
       Timeline  
Microsoft 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
BioNTech SE 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioNTech reported solid returns over the last few months and may actually be approaching a breakup point.

Microsoft and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft and BioNTech

The main advantage of trading using opposite Microsoft and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Microsoft and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk